Log in to save to my catalogue

Clinical significance of matrix metalloproteinase-9 in Fragile X Syndrome

Clinical significance of matrix metalloproteinase-9 in Fragile X Syndrome

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_878db1aaaa1d4d2a896a7ab00e7cd7b0

Clinical significance of matrix metalloproteinase-9 in Fragile X Syndrome

About this item

Full title

Clinical significance of matrix metalloproteinase-9 in Fragile X Syndrome

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2022-09, Vol.12 (1), p.15386-9, Article 15386

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

High plasma matrix metalloproteases-9 (MMP-9) levels have been reported in Fragile X Syndrome in a limited number of animal and human studies. Since the results obtained are method-dependent and not directly comparable, the clinical utility of MMP-9 measurement in FXS remains unclear. This study aimed to compare quantitative gel zymography and ELIS...

Alternative Titles

Full title

Clinical significance of matrix metalloproteinase-9 in Fragile X Syndrome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_878db1aaaa1d4d2a896a7ab00e7cd7b0

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_878db1aaaa1d4d2a896a7ab00e7cd7b0

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-022-19476-y

How to access this item